REIT - Healthcare Facilities
Compare Stocks
5 / 10Stock Comparison
MPW vs WELL vs VTR vs GMRE vs CHCT
Revenue, margins, valuation, and 5-year total return — side by side.
REIT - Healthcare Facilities
REIT - Healthcare Facilities
REIT - Healthcare Facilities
REIT - Healthcare Facilities
MPW vs WELL vs VTR vs GMRE vs CHCT — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | REIT - Healthcare Facilities | REIT - Healthcare Facilities | REIT - Healthcare Facilities | REIT - Healthcare Facilities | REIT - Healthcare Facilities |
| Market Cap | $3.37B | $149.25B | $41.15B | $94M | $505M |
| Revenue (TTM) | $972M | $11.63B | $6.13B | $148M | $122M |
| Net Income (TTM) | $-199M | $1.43B | $260M | $2M | $6M |
| Gross Margin | 55.7% | 39.1% | -4.3% | 68.8% | 62.8% |
| Operating Margin | 38.1% | 4.4% | 13.4% | 24.9% | 31.3% |
| Forward P/E | 49.4x | 78.4x | 118.0x | 595.7x | 37.6x |
| Total Debt | $128M | $21.38B | $13.22B | $654M | $536M |
| Cash & Equiv. | $541M | $5.03B | $741M | $7M | $3M |
MPW vs WELL vs VTR vs GMRE vs CHCT — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | Mar 26 | Return |
|---|---|---|---|
| Medical Properties … (MPW) | 100 | 31.3 | -68.8% |
| Welltower Inc. (WELL) | 100 | 408.8 | +308.8% |
| Ventas, Inc. (VTR) | 100 | 246.5 | +146.5% |
| Global Medical REIT… (GMRE) | 100 | 64.6 | -35.4% |
| Community Healthcar… (CHCT) | 100 | 46.9 | -53.1% |
Price return only. Dividends and distributions are not included.
Quick Verdict: MPW vs WELL vs VTR vs GMRE vs CHCT
Each card shows where this stock fits in a portfolio — not just who wins on paper.
MPW is the clearest fit if your priority is sleep-well-at-night.
- Lower volatility, beta 0.30, Low D/E 2.8%, current ratio 9.77x
WELL carries the broadest edge in this set and is the clearest fit for long-term compounding.
- 223.1% 10Y total return vs GMRE's 308.1%
- 35.8% FFO/revenue growth vs MPW's -2.4%
- 12.3% margin vs MPW's -20.4%
- +42.7% vs GMRE's +0.1%
VTR is the #2 pick in this set and the best alternative if growth exposure and defensive is your priority.
- Rev growth 18.5%, EPS growth 184.2%, 3Y rev CAGR 12.2%
- Beta 0.01, yield 2.1%, current ratio 0.96x
- Beta 0.01 vs CHCT's 0.60, lower leverage
GMRE ranks third and is worth considering specifically for income & stability.
- Dividend streak 5 yrs, beta 0.48, yield 63.5%
- 63.5% yield, 5-year raise streak, vs CHCT's 11.3%, (1 stock pays no dividend)
CHCT is the clearest fit if your priority is value.
- Lower P/E (37.6x vs 595.7x)
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 35.8% FFO/revenue growth vs MPW's -2.4% | |
| Value | Lower P/E (37.6x vs 595.7x) | |
| Quality / Margins | 12.3% margin vs MPW's -20.4% | |
| Stability / Safety | Beta 0.01 vs CHCT's 0.60, lower leverage | |
| Dividends | 63.5% yield, 5-year raise streak, vs CHCT's 11.3%, (1 stock pays no dividend) | |
| Momentum (1Y) | +42.7% vs GMRE's +0.1% | |
| Efficiency (ROA) | 2.3% ROA vs MPW's -1.3% |
MPW vs WELL vs VTR vs GMRE vs CHCT — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
Segment breakdown not available.
MPW vs WELL vs VTR vs GMRE vs CHCT — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
GMRE leads in 1 of 6 categories
WELL leads 1 • VTR leads 1 • MPW leads 0 • CHCT leads 0 • 3 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
Evenly matched — WELL and CHCT each lead in 2 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
WELL is the larger business by revenue, generating $11.6B annually — 95.0x CHCT's $122M. WELL is the more profitable business, keeping 12.3% of every revenue dollar as net income compared to MPW's -20.4%. On growth, WELL holds the edge at +40.3% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $972M | $11.6B | $6.1B | $148M | $122M |
| EBITDAEarnings before interest/tax | $663M | $2.8B | $2.3B | $95M | $82M |
| Net IncomeAfter-tax profit | -$199M | $1.4B | $260M | $2M | $6M |
| Free Cash FlowCash after capex | $0 | $2.5B | $1.4B | $19M | $60M |
| Gross MarginGross profit ÷ Revenue | +55.7% | +39.1% | -4.3% | +68.8% | +62.8% |
| Operating MarginEBIT ÷ Revenue | +38.1% | +4.4% | +13.4% | +24.9% | +31.3% |
| Net MarginNet income ÷ Revenue | -20.4% | +12.3% | +4.2% | +1.7% | +5.0% |
| FCF MarginFCF ÷ Revenue | +23.7% | +21.9% | +22.4% | +12.6% | +49.4% |
| Rev. Growth (YoY)Latest quarter vs prior year | +14.9% | +40.3% | +22.0% | +18.7% | +4.8% |
| EPS Growth (YoY)Latest quarter vs prior year | +123.2% | +22.5% | 0.0% | -166.2% | +124.4% |
Valuation Metrics
GMRE leads this category, winning 3 of 6 comparable metrics.
Valuation Metrics
At 115.3x trailing earnings, GMRE trades at a 50% valuation discount to CHCT's 228.4x P/E. On an enterprise value basis, GMRE's 8.3x EV/EBITDA is more attractive than MPW's 105.4x.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $3.4B | $149.2B | $41.1B | $94M | $505M |
| Enterprise ValueMkt cap + debt − cash | $3.0B | $165.6B | $53.6B | $741M | $1.0B |
| Trailing P/EPrice ÷ TTM EPS | -17.12x | 153.25x | 160.26x | 115.29x | 228.42x |
| Forward P/EPrice ÷ next-FY EPS est. | 49.43x | 78.42x | 118.01x | 595.67x | 37.62x |
| PEG RatioP/E ÷ EPS growth rate | — | — | — | — | — |
| EV / EBITDAEnterprise value multiple | 105.41x | 66.40x | 24.31x | 8.35x | 16.27x |
| Price / SalesMarket cap ÷ Revenue | 3.47x | 13.99x | 7.05x | 0.68x | 4.17x |
| Price / BookPrice ÷ Book value/share | 0.74x | 3.35x | 3.18x | 0.17x | 1.11x |
| Price / FCFMarket cap ÷ FCF | 14.62x | 52.41x | 31.25x | — | 8.95x |
Profitability & Efficiency
Evenly matched — MPW and WELL each lead in 3 of 9 comparable metrics.
Profitability & Efficiency
WELL delivers a 3.5% return on equity — every $100 of shareholder capital generates $3 in annual profit, vs $-4 for MPW. MPW carries lower financial leverage with a 0.03x debt-to-equity ratio, signaling a more conservative balance sheet compared to CHCT's 1.25x. On the Piotroski fundamental quality scale (0–9), WELL scores 7/9 vs GMRE's 4/9, reflecting strong financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | -4.3% | +3.5% | +2.1% | +0.5% | +1.4% |
| ROA (TTM)Return on assets | -1.3% | +2.3% | +1.0% | +0.2% | +0.6% |
| ROICReturn on invested capital | — | +0.5% | +2.5% | +2.0% | +1.6% |
| ROCEReturn on capital employed | — | +0.6% | +3.2% | +5.3% | +2.8% |
| Piotroski ScoreFundamental quality 0–9 | 5 | 7 | 6 | 4 | 5 |
| Debt / EquityFinancial leverage | 0.03x | 0.49x | 1.05x | 1.18x | 1.25x |
| Net DebtTotal debt minus cash | -$413M | $16.3B | $12.5B | $647M | $533M |
| Cash & Equiv.Liquid assets | $541M | $5.0B | $741M | $7M | $3M |
| Total DebtShort + long-term debt | $128M | $21.4B | $13.2B | $654M | $536M |
| Interest CoverageEBIT ÷ Interest expense | — | 0.26x | 1.40x | 1.14x | 1.15x |
Total Returns (Dividends Reinvested)
WELL leads this category, winning 5 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in WELL five years ago would be worth $30,234 today (with dividends reinvested), compared to $4,381 for MPW. Over the past 12 months, WELL leads with a +42.7% total return vs GMRE's +0.1%. The 3-year compound annual growth rate (CAGR) favors WELL at 42.5% vs CHCT's -13.9% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | +13.0% | +14.3% | +12.6% | +6.9% | +11.2% |
| 1-Year ReturnPast 12 months | +18.6% | +42.7% | +33.9% | +0.1% | +14.5% |
| 3-Year ReturnCumulative with dividends | -16.9% | +189.5% | +94.2% | +5.6% | -36.1% |
| 5-Year ReturnCumulative with dividends | -56.2% | +202.3% | +74.8% | -21.4% | -45.6% |
| 10-Year ReturnCumulative with dividends | -0.3% | +223.1% | +65.0% | +308.1% | +83.9% |
| CAGR (3Y)Annualised 3-year return | -6.0% | +42.5% | +24.8% | +1.8% | -13.9% |
Risk & Volatility
VTR leads this category, winning 2 of 2 comparable metrics.
Risk & Volatility
VTR is the less volatile stock with a 0.01 beta — it tends to amplify market swings less than CHCT's 0.60 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. VTR currently trades 97.8% from its 52-week high vs GMRE's 89.5% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.30x | 0.13x | 0.01x | 0.48x | 0.60x |
| 52-Week HighHighest price in past year | $5.92 | $219.59 | $88.50 | $39.93 | $18.22 |
| 52-Week LowLowest price in past year | $3.95 | $142.65 | $61.76 | $29.05 | $13.23 |
| % of 52W HighCurrent price vs 52-week peak | +95.4% | +97.0% | +97.8% | +89.5% | +97.0% |
| RSI (14)Momentum oscillator 0–100 | 58.9 | 60.2 | 56.2 | 52.7 | 56.9 |
| Avg Volume (50D)Average daily shares traded | 1.8M | 2.6M | 3.4M | 130K | 228K |
Analyst Outlook
Evenly matched — GMRE and CHCT each lead in 1 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: MPW as "Hold", WELL as "Buy", VTR as "Buy", GMRE as "Buy", CHCT as "Hold". Consensus price targets imply 11.9% upside for GMRE (target: $40) vs -11.5% for MPW (target: $5). For income investors, GMRE offers the higher dividend yield at 63.51% vs WELL's 1.30%.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Hold | Buy | Buy | Buy | Hold |
| Price TargetConsensus 12-month target | $5.00 | $226.50 | $90.80 | $40.00 | $18.50 |
| # AnalystsCovering analysts | 28 | 34 | 32 | 22 | 16 |
| Dividend YieldAnnual dividend ÷ price | — | +1.3% | +2.1% | +63.5% | +11.3% |
| Dividend StreakConsecutive years of raises | 0 | 2 | 1 | 5 | 11 |
| Dividend / ShareAnnual DPS | — | $2.76 | $1.86 | $22.70 | $2.00 |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | 0.0% | 0.0% | 0.0% | +0.4% |
GMRE leads in 1 of 6 categories (Valuation Metrics). WELL leads in 1 (Total Returns). 3 tied.
MPW vs WELL vs VTR vs GMRE vs CHCT: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is MPW or WELL or VTR or GMRE or CHCT a better buy right now?
For growth investors, Welltower Inc.
(WELL) is the stronger pick with 35. 8% revenue growth year-over-year, versus -2. 4% for Medical Properties Trust, Inc. (MPW). Global Medical REIT Inc. (GMRE) offers the better valuation at 115. 3x trailing P/E (595. 7x forward), making it the more compelling value choice. Analysts rate Welltower Inc. (WELL) a "Buy" — based on 34 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — MPW or WELL or VTR or GMRE or CHCT?
On trailing P/E, Global Medical REIT Inc.
(GMRE) is the cheapest at 115. 3x versus Community Healthcare Trust Incorporated at 228. 4x. On forward P/E, Community Healthcare Trust Incorporated is actually cheaper at 37. 6x — notably different from the trailing picture, reflecting expected earnings growth.
03Which is the better long-term investment — MPW or WELL or VTR or GMRE or CHCT?
Over the past 5 years, Welltower Inc.
(WELL) delivered a total return of +202. 3%, compared to -56. 2% for Medical Properties Trust, Inc. (MPW). Over 10 years, the gap is even starker: GMRE returned +308. 1% versus MPW's -0. 3%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — MPW or WELL or VTR or GMRE or CHCT?
By beta (market sensitivity over 5 years), Ventas, Inc.
(VTR) is the lower-risk stock at 0. 01β versus Community Healthcare Trust Incorporated's 0. 60β — meaning CHCT is approximately 6216% more volatile than VTR relative to the S&P 500. On balance sheet safety, Medical Properties Trust, Inc. (MPW) carries a lower debt/equity ratio of 3% versus 125% for Community Healthcare Trust Incorporated — giving it more financial flexibility in a downturn.
05Which is growing faster — MPW or WELL or VTR or GMRE or CHCT?
By revenue growth (latest reported year), Welltower Inc.
(WELL) is pulling ahead at 35. 8% versus -2. 4% for Medical Properties Trust, Inc. (MPW). On earnings-per-share growth, the picture is similar: Ventas, Inc. grew EPS 184. 2% year-over-year, compared to -94. 6% for Global Medical REIT Inc.. Over a 3-year CAGR, WELL leads at 22. 7% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — MPW or WELL or VTR or GMRE or CHCT?
Welltower Inc.
(WELL) is the more profitable company, earning 8. 8% net margin versus -20. 4% for Medical Properties Trust, Inc. — meaning it keeps 8. 8% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: MPW leads at 38. 1% versus 3. 3% for WELL. At the gross margin level — before operating expenses — GMRE leads at 78. 9%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is MPW or WELL or VTR or GMRE or CHCT more undervalued right now?
On forward earnings alone, Community Healthcare Trust Incorporated (CHCT) trades at 37.
6x forward P/E versus 595. 7x for Global Medical REIT Inc. — 558. 0x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for GMRE: 11. 9% to $40. 00.
08Which pays a better dividend — MPW or WELL or VTR or GMRE or CHCT?
In this comparison, GMRE (63.
5% yield), CHCT (11. 3% yield), VTR (2. 1% yield), WELL (1. 3% yield) pay a dividend. MPW does not pay a meaningful dividend and should not be held primarily for income.
09Is MPW or WELL or VTR or GMRE or CHCT better for a retirement portfolio?
For long-horizon retirement investors, Ventas, Inc.
(VTR) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 01), 2. 1% yield). Both have compounded well over 10 years (VTR: +65. 0%, MPW: -0. 3%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between MPW and WELL and VTR and GMRE and CHCT?
Both stocks operate in the Real Estate sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: MPW is a small-cap quality compounder stock; WELL is a mid-cap high-growth stock; VTR is a mid-cap high-growth stock; GMRE is a small-cap income-oriented stock; CHCT is a small-cap income-oriented stock. WELL, VTR, GMRE, CHCT pay a dividend while MPW does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.